SCHEMBL3725056

SCHEMBL3725056

O=C(O)N1CCC(N(c2ccccc2)S(=O)(=O)c2ccc(C(F)(F)F)cc2)CC1.O=C(O)N1CCC(n2c(=O)[nH]c3ccccc32)C[C@@H]1CCCN(Cc1ccccc1)Cc1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 6/20 0.42
▸ CHRM1 P11229 4/20 0.38
▸ LMNA P02545 3/20 0.38
▸ HTR1A P08908 3/20 0.38
▸ DRD2 P14416 3/20 0.38
▸ HTR2A P28223 3/20 0.38
▸ DRD3 P35462 3/20 0.38
▸ KCNH2 Q12809 3/20 0.38
▸ MLNR O43193 2/20 0.38
▸ PGR P06401 2/20 0.38
▸ ADRB2 P07550 2/20 0.38
▸ CHRM2 P08172 2/20 0.38
▸ ADRB1 P08588 2/20 0.38
▸ ADRA2A P08913 2/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ ADRA2B P18089 2/20 0.38
▸ ADRA2C P18825 2/20 0.38
▸ DRD1 P21728 2/20 0.38
▸ DRD4 P21917 2/20 0.38
▸ SLC6A2 P23975 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3725678 0.88 HSD11B1 (0.35) HSD11B1CHRM1LMNAHTR1ADRD2
SCHEMBL4814429 0.88 HSD11B1 (0.35) HSD11B1CHRM1LMNAHTR1ADRD2
SCHEMBL1837901 0.87 CHRM1 (0.49) HSD11B1CHRM1LMNAHTR1ADRD2
SCHEMBL1838176 0.85 OPRK1 (0.50) HSD11B1CHRM1LMNAHTR1ADRD2
SCHEMBL1836260 0.85 OPRK1 (0.50) HSD11B1CHRM1LMNAHTR1ADRD2
SCHEMBL3802467 0.83 HTR1A (0.47) HSD11B1CHRM1LMNAHTR1ADRD2
SCHEMBL1836591 0.82 PLD1 (0.51) HSD11B1CHRM1LMNAHTR1ADRD2
SCHEMBL1835272 0.80 OPRM1 (0.50) CHRM1LMNAHTR1ADRD2HTR2A
SCHEMBL3403017 0.80 OPRM1 (0.50) CHRM1LMNAHTR1ADRD2HTR2A
SCHEMBL3722537 0.80 OPRM1 (0.39) CHRM1HTR2AHTR2CCHRM3OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP claimed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO claimed
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback